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By nature, biomarker is the measurable change associated with a physiological or pathophysiological process. Unlike blood 
which has mechanisms to minimize changes and to keep the internal environment homeostatic, urine is more likely to reflect 
changes of the body and is a better biomarker source. Because of its potential in biomarker discovery, urinary proteins should 
be preserved comprehensively as the duration of the patients’ corresponding medical records. Here, we propose a method to 
adsorb urinary proteins onto a membrane we named Urimem. This simple and inexpensive method requires minimal sample 
handling, uses no organic solvents, and is environmentally friendly. Urine samples were filtered through the membrane, and 
urinary proteins were adsorbed onto the membrane. The proteins on the membrane were dried and stored in a vacuum bag, 
which keeps the protein pattern faithfully preserved. The membrane may even permit storage at room temperature for weeks. 
Using this simple and inexpensive method, it is possible to begin preserving urine samples from all consenting people. Thus, 
medical research especially biomarker research can be conducted more economically. Even more objective large-scale pro-
spective studies will be possible. This method has the potential to change the landscape of medical research and medical prac-
tice. 
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Biological samples from patients are invaluable for both 
medical research and clinical practice. However, such sam-
ples are not currently preserved as comprehensively or for 
as long as their corresponding medical records, primarily 
because of the invasiveness, difficulty and cost associated 
with their collection and storage. By nature, biomarker is 
the measurable change associated with a physiological or 
pathophysiological process (http://blog.sciencenet.cn/blog- 
244733-725226.html). Unlike blood which has mechanisms 
to keep the internal environment homeostatic, urine is more 
likely to reflect changes of the body. In other words, urine is 
likely to be a better biomarker source than blood [1]. 
Therefore, urine, as an important biomarker source, should 
be preserved for each stage of the disease for all patients. 
The preservation of a large number of urinary samples for 
validation is a critical step that facilitates biomarker re-
search and its translation from the laboratory to the clinic. 
The preservation of urine was commonly performed by 
freezing the urine and storing it at 80°C; however, this 
requires a significant amount of space because of its large 
volume and low protein concentration. Furthermore, the 
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freezing of urine cannot absolutely prevent the degradation 
of the urinary proteins since proteins are more easily de-
graded in liquid than under completely dry conditions. 
Simple and inexpensive urinary protein sample preserva-
tion can be the starting point for long and comprehensive 
biological sample storage. Here, we propose a method for 
directly adsorbing urinary proteins onto a polyvinylidene 
difluoride (PVDF) membrane that can then be dried and 
stored. This method is simple and inexpensive and requires 
minimal sample handling, avoids the use of organic solvents 
and is environmentally friendly. Importantly, the proteins 
bound to the membrane are dry, which prevents their deg-
radation and allows them to be preserved at room tempera-
ture for longer periods. Because PVDF membranes have a 
limited protein-loading capacity, it is important to ensure 
that the proteins in a given urine sample are all adsorbed 
onto the membrane, in order to preserve the protein pattern 
faithfully.  
1  Materials and methods 
1.1  Ethical approval 
This study aimed to establish a method using PVDF mem-
branes to preserve urinary proteins. Urine was collected 
from volunteer students in our laboratory. No invasive 
measures were required, and all participants provided verbal 
informed consent to allow their urine samples to be used for 
this study. Written consent was not considered to be neces-
sary, but the record of verbal consent was documented by 
the authors in the laboratory notebook. The verbal consent 
procedure and research protocol were approved by the 
Medical Ethics Committee of Peking Union Medical Col-
lege (Project No. 018-2013). 
1.2  Urinary protein preservation on the membrane 
A flow chart explaining the method is shown in Figure 1. 
The procedure was carried out as follows. (i) The urinary 
protein concentration was determined from previous routine 
urine tests. In the case of proteinuria, the urinary protein 
concentration was determined and the urine was diluted to a 
normal human urinary protein concentration of <100 mg L1. 
The filter paper used was 47-mm diameter medium-speed 
qualitative filter paper, and the PVDF membranes were 
Immobilon-PSQ Membrane (PVDF, 0.2 µm, Millipore, 
Headquartered in Billerica, Massachusetts). (ii) The diluted 
samples were centrifuged in a thermostatic centrifuge for  
10 min at 12000×g and 4°C and the supernatant was saved. 
As an optional stage, 20 mL diluted urine sample was 
passed through a 0.45-μm filter membrane (Durapore mem-
brane filters, filter type: 0.45 µm HV, Millipore, Headquar-
tered in Billerica, Massachusetts) with ultra-low pro-
tein-binding capacity and the flow-through was saved. (iii) 
Four to six sheets of wetted circular filter paper were placed 
onto the vacuum suction filter bottle (10-cm2 filter area). (iv) 
One activated PVDF membrane (activated in methanol and 
rinsed with pure water) was placed immediately onto the 
filter paper, avoiding the generation of bubbles. (v) The 
vacuum suction filter bottle was installed and loaded with 
20 mL supernatant or the flow-through from the 0.45-μm 
filter membrane. (vi) The vacuum suction filter bottle was 
connected to the vacuum pump, and the solution allowed 
passing through the PVDF membrane drop-wise, by adjust-
ing the vacuum pressure to approximately 7 kPa, with an 
initial velocity of approximately 1.3 droplets s1. The total 
filtration time was approximately 4 min. (vii) After the pro-
teins were adsorbed onto the PVDF membrane, the pro-
tein-bound membrane was placed under four 275 W bulbs 
for 3–4 min to complete the drying process, or left to dry at 
room temperature. (viii) The dry membrane with tag paper 
was placed between aseptic sealing membranes to keep the 
tag paper and dry membrane separate. The membrane was 
then sealed using a kitchen vacuum sealer and stored at 
80°C. The tag paper contained a unique number, which 
could be cross-referenced with other information relevant to 
the sample (medical record number, date and time urine was 
collected, before or after taking drugs, routine urine test 
number), and stored on the computer.   
1.3  Urinary protein elution from the membrane 
The elution buffer was composed of 1% Triton X-100 and 
2% sodium dodecyl sulfate (SDS) in 50 mmol L1 Tris-HCl, 
pH 9.5 [2]. Briefly, the protein-bound dry membrane was 
cut into small pieces and placed in a clean tube, to which 
0.1 mL elution buffer cm2 membrane was added. The 
membrane in the elution buffer was mixed well by first  
 
 
Figure 1  The flow chart of this method. 
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vortexing for 10 min at room temperature and then by ul- 
trasound for 15 min in an ultrasonic cleaner at room temp- 
erature. The supernatant was collected by spinning down 
the membrane. The protein could be precipitated with chlo-
roform/methanol if the detergent needed to be removed for 
downstream analyses, such as protein quantification and 
liquid chromatography-tandem mass spectrometry (LC- 
MS/MS) analysis.  
2  Results 
2.1  Loading capacity of the PVDF membrane 
Different volumes of centrifuged urine were passed through 
10-cm2 PVDF membranes and the filtrates were then passed 
through new PVDF membranes to detect proteins not ad-
sorbed by the first membrane. The protein-bound mem-
branes were dried completely at room temperature, and the 
proteins were eluted using 1 mL elution buffer. Equal vol-
umes (30 μL) of elution buffer were separated by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) (12% gels) 
and stained with Coomassie Brilliant Blue (Figure 2). 
Comparison of the first and second adsorptions of 20 mL 
urine each (20 F and 20 S, respectively) revealed that most 
of the proteins were adsorbed on the membrane at the first 
adsorption. Thus 20 mL urine per 10 cm2 membrane al-
lowed almost complete preservation of urinary proteins on 
the PVDF membrane under these conditions. The protein 
concentrations of the urine samples were about 33 μg mL1, 
equivalent to 66 μg cm2 in this experiment.  
 
 
Figure 2  The loading capacity of the PVDF membrane was tested using 
SDS-PAGE analysis. The numbers refer to the volume of urine used in mL. 
F refers to protein eluted from the first membrane adsorption; S refers to 
protein eluted from the second membrane adsorption (e.g., 20 S=proteins 
eluted from second membrane adsorption of 20 mL urine). Most of the 
proteins were adsorbed on the membrane during the first adsorption. 
2.2  The urinary proteins recovered from the mem-
brane preserved for 18 d at 80℃ and at room temper-
ature exhibit the same SDS-PAGE pattern 
Four 20-mL aliquots of urine were passed through four 
10-cm2 PVDF membrane sheets and then stored under four 
different temperature conditions for 18 d: room temperature, 
4°C, 20°C, and 80°C. Proteins were eluted from the 
PVDF membranes with 1 mL elution buffer, separated in 30 
μL elution buffer by SDS-PAGE (12% gels) and stained 
with Coomassie Brilliant Blue. Urinary proteins stored at 
different temperatures exhibited similar SDS- PAGE pat-
terns (Figure 3).  
3  Discussion  
As difficult as it is to believe today, a single concept devel-
oped by Dr. Henry Plummer at the beginning of the 20th 
century changed the face of medicine. This concept in-
volved a centralized medical record that was stored in a 
single repository and capable of traveling with the patient 
[3]. This concept is also applicable to the field of biological 
sample preservation, and comprehensive storage of biolog-
ical samples could further revolutionize medical research 
and practice. Urinary proteins provide rich biological in- 
 
 
Figure 3  Urinary proteins recovered from membranes after preservation 
for 18 d at different temperatures. Four 20-mL aliquots of urine were 
passed through four 10-cm2 PVDF membrane  sheets and stored for 18 d at 
four temperatures: room temperature (RT), 4°C, 20 °C, and 80°C. After 
protein elution from the PVDF membrane with 1 mL elution buffer, 30 μL 
elution buffers were analyzed by SDS-PAGE. 
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formation of the body especially those changes we called 
biomarkers. Without the homeostasis mechanisms, urine is 
more likely to preserve the changes and become the gold 
mine of biomarker research. The current study was the first 
to report the use of a PVDF membrane to preserve urinary 
proteins. Urinary proteins from as much as 20 mL urine 
were preserved on 10-cm2 PVDF membrane within 5 min or 
less. The membranes could be stored dry in a vacuum bag, 
thus preventing protein degradation and facilitating sample 
transfer between institutions. Samples could also be pre-
served using nitrocellulose (NC) membranes, using a simi-
lar method.  
Proteins preserved on PVDF/NC membranes can subse-
quently be analyzed using traditional downstream analytical 
applications. Adsorbed proteins can be stained with all 
commonly-used protein stains, such as Ponceau-S Red, 
Coomassie Brilliant Blue R dye, and Amido Black, enabling 
quantification of the protein on the membrane [4–6]. Pro-
teins on the membrane can also be subjected to immunode-
tection by dot blotting, and the preserved proteins can be 
eluted from the membrane for other applications, such as 
Western blotting or LC-MS/MS analysis [2,7].  
This simple and inexpensive method of preserving uri-
nary proteins makes it possible to begin preserving urine 
samples from all consenting patients during each stage of 
disease development. However, several factors need to be 
considered. Samples taken at certain time points should be 
well-documented in the patient’s medical record, and pa-
tient consent may be required, both when the sample is col-
lected, and when it is analyzed as part of a particular study. 
Once urinary protein storage becomes an accepted practice 
by the medical community, technical standards and com-
mercial products are likely to be developed. New technolo-
gies may emerge, including more durable media with im-
proved protein-adsorption capabilities, test strips to estimate 
protein quantity, streamlined protocols for urinary protein 
collection, drying, sealing, packaging and labeling, sample 
storage and management systems for individual sample ac-
cess and retrieval, and optimal procedures for the use of 
membrane-adsorbed proteins. Storage at 4°C or even at am- 
bient temperatures for longer periods may become feasible, 
while the use of resins might make the preservation of small 
molecules, including creatinine and certain ions, an eco-
nomic prospect. Other body fluids, such as cerebrospinal 
fluid, can also be stored using the same approach.  
Comprehensive historical biological information can also 
be used in both prospective and retrospective studies to im-
prove our understanding of the pathophysiology of certain 
diseases and potential relationships among diseases, or for 
monitoring the long-term efficacies and side effects of 
treatments. More ways of extracting and using the infor-
mation will become evident as increasing numbers of sam-
ples become available for research. This information will 
make medical research easier, faster, and more economic, 
ultimately benefiting the patients who provided the samples.  
We believe that the current technique provides a practical 
method for preserving urinary protein samples from con-
senting people during every stage of the disease develop-
ment. Even more objective large scale prospective studies 
will be possible. This procedure has the potential to change 
the current landscape of medical research and medical prac-
tice. 
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